Genentech Clinical Trials T-DM1 and Omnitarg
T-DM1 & PERTUZUMAB TRIAL LISTINGS
T-DM1 1. EMILIA: An Open-Label Study of Trastuzumab-MCC-DM1 (TDM-1) vs. Capecitabine + Lapatinib in Patients With HER2-Positive Locally Advanced or Metastatic Breast Cancer a. ClinicalTrials.gov Identifier: NCT00829166 b. Recruiting; Global c. Ph III d. Condition: mBC e. Interventions: Drug: capecitabine; Drug: lapatinib; Drug: trastuzumab – MCC-DM1 2. A Study of the Efficacy and Safety of Trastuzumab-Mcc-DM1 vs. Trastuzumab (Herceptin®) and Docetaxel (Taxotere®) in Patients With Metastatic HER2-Positive Breast Cancer Who Have Not Received Prior Chemotherapy for Metastatic Disease a. ClinicalTrials.gov Identifier: NCT00679341 b. Recruiting; Global c. Ph II d. Conditions: mBC e. Interventions: Drug: docetaxel; Drug: trastuzumab; Drug: trastuzumab – MCC – DM1 3. A Study of Trastuzumab-MCC-DM1 (T-DM1) in Combination With Pertuzumab Administered to Patients With HER2-Positive Locally Advanced or Metastatic Breast Cancer Who Have Previously Received Trastuzumab a. ClinicalTrials.gov Identifier: NCT00875979 b. Recruiting; Global c. Ph I & II d. Conditions: mBC e. Interventions: Drug: pertuzumab; Drug: trastuzumab – MCC – DM1 4. An Extension Study of T-DM1 in Patients Previously Treated With TDM-1 a. ClinicalTrials.gov Identifier: NCT00781612 b. Enrolling by invitation; US c. Ph II d. Conditions: mBC e. Intervention: Drug: trastuzumab – MCC – DM1 . Pertuzumab 1. A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-positive Metastatic Breast Cancer (CLEOPATRA) a. ClinicalTrials.gov Identifier: NCT00567190 b. Enrolling c. Ph III d. Condition: BC e. Intervention: Drug: pertuzumab; Drug: docetaxel; Drug: placebo; Drug: trastuzumab 2. A Study of Pertuzumab in Combination with Herceptin in Patients With HER2 Positive Breast Cancer (NEOSPHERE) a. ClinicalTrials.gov Identifier: NCT00545688 b. Recruiting; Conducted outside of the US c. Ph II d. Condition: BC e. Interventions: Drug: pertuzumab; Drug: Herceptin; Drug: docetaxel Regards Joe |
Hi Joe,
for what it's worth, you can also search clinical trials here: It looks like it gets its data from clinical trials.gov but it will pinpoint trial locations (and contacts) when they are available. below is a link for tdm1 trials http://www.fdable.com/clinical_trials/query/3205c3d54840 |
All times are GMT -7. The time now is 01:13 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021